|
|
|
|
Direct Cost |
Indirect Cost |
|
271201100006I-0-27100007-1 |
RAPIDLY-ACTING TREATMENTS FOR TREATMENT-RESISTANT DEPRESSION (RAPID) |
MASSACHUSETTS GENERAL HOSPITAL |
NIMH |
|
|
$109,398 |
271201100006I-4-27100002-1 |
IGF::OT::IGF RAPIDLY-ACTING TREATMENTS FOR TREATMENT-RESISTANT DEPRESSION (RAPID) |
MASSACHUSETTS GENERAL HOSPITAL |
NIMH |
|
|
$143,962 |
1DP2AR068272-01 |
Glycoengineering In Vivo |
MASSACHUSETTS GENERAL HOSPITAL |
NIAMS |
$1,500,000 |
$1,110,000 |
$2,610,000 |
1DP5OD019833-01 |
Memory network dysfunction as an early marker of preclinical Alzheimer's Disease |
MASSACHUSETTS GENERAL HOSPITAL |
OD |
$253,200 |
$173,900 |
$427,100 |
1F32AI108125-01A1 |
CCR8 positive T cells and chronic allergic inflammation in asthma |
MASSACHUSETTS GENERAL HOSPITAL |
NIAID |
$63,122 |
|
$63,122 |
1F32AI114406-01 |
Enhancing mucosal protection through antibody interactions with mucin proteins |
MASSACHUSETTS GENERAL HOSPITAL |
NIAID |
$51,530 |
|
$51,530 |
1F32CA183465-01A1 |
INVESTIGATION OF THE VASCULAR RESPONSE IN LYMPH NODE METASTASES |
MASSACHUSETTS GENERAL HOSPITAL |
NCI |
$53,282 |
|
$53,282 |
1F32DK101159-01 |
Characterization of Noncoding Mutations in Inflammatory Bowel Disease |
MASSACHUSETTS GENERAL HOSPITAL |
NIDDK |
$58,946 |
|
$58,946 |
1F32DK103471-01 |
Epigenetic modulation of metabolism and development by TOR complex 2 |
MASSACHUSETTS GENERAL HOSPITAL |
NIDDK |
$53,282 |
|
$53,282 |
1F32DK103500-01 |
Expanding the pool of transplantable human livers by modeling perfusion dynamics |
MASSACHUSETTS GENERAL HOSPITAL |
NIDDK |
$56,030 |
|
$56,030 |
1F32GM109693-01 |
Examining regulatory roles for long non-coding RNAs on Polycomb group functions |
MASSACHUSETTS GENERAL HOSPITAL |
NIGMS |
$53,282 |
|
$53,282 |
1F32HD078029-01A1 |
The regulatory role of chromatin interaction in pluripotency and differentiation |
MASSACHUSETTS GENERAL HOSPITAL |
NICHD |
$55,094 |
|
$55,094 |
1F32HD078083-01A1 |
Kisspeptin Physiology Across Reproductive Development |
MASSACHUSETTS GENERAL HOSPITAL |
NICHD |
$60,998 |
|
$60,998 |
1F32HD079225-01A1 |
Identifying regulators of the naive and primed pluripotent state |
MASSACHUSETTS GENERAL HOSPITAL |
NICHD |
$53,282 |
|
$53,282 |
1F32HD081844-01 |
Predicting Metformin Response in Polycystic Ovary Syndrome |
MASSACHUSETTS GENERAL HOSPITAL |
NICHD |
$65,448 |
|
$65,448 |
1F32HL124951-01 |
The Role and Consequences of Anemia in Children with Pneumonia |
MASSACHUSETTS GENERAL HOSPITAL |
NHLBI |
$67,622 |
|
$67,622 |
1F33GM109574-01 |
Isolating clinically important cells from large fluid volumes with microfluidics |
MASSACHUSETTS GENERAL HOSPITAL |
NIGMS |
$40,092 |
|
$40,092 |
1K01AI110524-01 |
Improving clinical, operational and economic outcomes related to MRSA |
MASSACHUSETTS GENERAL HOSPITAL |
NIAID |
$127,000 |
$9,698 |
$136,698 |
1K01AR066716-01 |
Role of SCARF1 in Human Lupus |
MASSACHUSETTS GENERAL HOSPITAL |
NIAMS |
$122,750 |
$9,820 |
$132,570 |
1K01AT008225-01 |
MBCT effects on brain mechanisms of interoceptive awareness and rumination in MDD |
MASSACHUSETTS GENERAL HOSPITAL |
NCCAM |
$127,000 |
$10,160 |
$137,160 |